2016 American Transplant Congress
De Novo DQA/DQB Donor Specific Antibodies (DSA) Is Associated with Allograft Dysfunction in Pediatric Liver Transplantation (LT).
Yale New Haven Transplantation Center, New Haven.
Antibody mediated rejection following LT is thought to be uncommon. Studies suggest HLA Ab that bind C1q may be deleterious to the TX allograft, &…2016 American Transplant Congress
Hepatitis B Immune Globulin Withdrawal in HBsAg Positive Liver Transplant Patients.
Introduction: Liver transplantation for chronic hepatitis B virus (HBV) is associated with a high recurrence rate of HBV post-transplant without the use of prophylaxis. The…2016 American Transplant Congress
Live Donor Champion Program: Time to Redefine Living Liver Donation.
UVA Surgery, Charlottesville, VA.
Live Donor Champion (LDC) Programs promote the advocacy for living donor transplantation by patients' family members or friends. Hereby, we conducted a prospective 9 month…2016 American Transplant Congress
Is Pretransplant Determination of Hepatocellular Carcinoma Tumor Grade Using Needle Biopsy Reliable for Transplant Candidate Selection? Analysis of 217 Liver Transplant Recipients.
Department of Surgery, UCLA, Los Angeles, CA.
Objective: Despite the prognostic significance of tumor grade and vascular invasion for patients with hepatocellular carcinoma (HCC), preoperative needle biopsy (PNB) is not routinely utilized…2016 American Transplant Congress
Biliary Epithelial Damage, Regenerative Capacity and Local Immune Response After Cold Storage of DBD Livers Determine Biliary Complications After Liver Transplantation.
Department of Surgery, University Medical Center Regensburg, Regensburg, Germany.
Background: The aim of this study was to examine the development and molecular mechanisms of bile duct (BD) damage between organ retrieval and transplantation and…2016 American Transplant Congress
A Comparative Intention-to-Treat Analysis of Liver Transplantation for HCC – Living Donor Liver Transplant vs. Deceased Donor Liver Transplant.
Multi-Organ Transplant Program, University of Toronto, Toronto, ON, Canada.
IntroductionLiving donor liver transplantation (LDLT) can reduce waiting times and potentially decrease drop-out rates for cirrhotic patients with HCC. However, it has also been reported…2016 American Transplant Congress
Outcomes of Ductoplasty in Right Lobe Living Donor Grafts with More Than One Bile Duct.
Background:Biliary complications remain the Achilles's heel of LDLT, especially in the setting of multiple ducts in the right lobe graft. Hilar plate glissonian sheath preservation…2016 American Transplant Congress
Diabetes Mellitus Status of the Donor and Prolonged Cold Ischemia Time Have a Synergistic Negative Effect on Graft Survival After Liver Transplantation.
Background: Both prolonged cold ischemia time (CIT) and a history of diabetes mellitus (DM) in the donor are associated with reduced graft survival after liver…2016 American Transplant Congress
Results from 100 Consecutive Donation-After-Circulatory Death (DCD) Liver Transplants Using a Thrombolytic Protocol.
Multi-Organ Transplant Institute, Ochsner Clinic Foundation, New Orleans, LA.
Background: In early 2010, our center implemented a thrombolytic protocol for DCD liver transplantation in an effort to reduce biliary complications and improve graft survival.…2016 American Transplant Congress
Tissue Inhibitor of Metalloproteinase-3 (TIMP-3) Protects Against Loss of Hepatic Integrity After Ischemia-Reperfusion Injury.
Surgery, The Dumont-UCLA Transplant Center, Los Angeles, CA.
Liver ischemia-reperfusion injury (IRI) remains a challenging problem in clinical orthotopic liver transplantation (OLT). Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular matrix (ECM)-associated protein…
- « Previous Page
- 1
- …
- 158
- 159
- 160
- 161
- 162
- …
- 180
- Next Page »